Company Foundation

Foundation Medicine is a molecular information company leading the field of precision oncology by providing comprehensive genomic profiling (CGP) to identify the molecular alterations in a patient's cancer. The company's suite of FDA-approved diagnostic tests, including FoundationOne CDx and FoundationOne Liquid CDx, helps physicians match patients with relevant targeted therapies, immunotherapies, and clinical trials. By leveraging a massive database of genomic insights, Foundation Medicine also partners with biopharmaceutical companies to accelerate the development of new precision medicines. Since its acquisition by Roche, the company has expanded its global footprint while remaining a critical player in the integration of genomic data into routine clinical care.